Home › Metabolic Disorders › California › Los Angeles
Metabolic Disorders clinical trials in Los Angeles, CA
4 studies for Metabolic Disorders are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Los Angeles
- 89bio Clinical Study Site, Los Angeles
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
RecruitingPhase 1/2
- Ronald Reagan UCLA Medical Center, Los Angeles
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
RecruitingPhase 1/2
- UCSD Altman Clinical and Transalational Research Institute Building, Los Angeles
- Ronald Reagan UCLA Medical Center, Los Angeles
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Recruiting
- Angel City Research, Los Angeles
- Clemente Clinical Research, Los Angeles
About Metabolic Disorders
Your metabolism makes energy from the food you eat. A metabolic disorder disrupts this process. One example is diabetes. Learn more.
More about Metabolic Disorders on MedlinePlus
Metabolic Disorders trials in other cities
- Washington, DC11 studies
- Ann Arbor, MI8 studies
- St. Louis, MO7 studies
- Durham, NC7 studies
- New York City, NY7 studies
- Baltimore, MD6 studies
- Chicago, IL6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Miami, FL4 studies
- Seattle, WA4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.